Your browser doesn't support javascript.
loading
Gonadotropin-Releasing Hormone Analogs for Treatment of Central Precocious Puberty in Children Younger than 2 Years of Age.
Gohil, Anisha; Eugster, Erica A.
Affiliation
  • Gohil A; Division of Endocrinology & Diabetes, Department of Pediatrics, Riley Hospital for Children at IU Health, Indiana University School of Medicine, Indianapolis, IN. Electronic address: agohil@iu.edu.
  • Eugster EA; Division of Endocrinology & Diabetes, Department of Pediatrics, Riley Hospital for Children at IU Health, Indiana University School of Medicine, Indianapolis, IN.
J Pediatr ; 244: 215-218, 2022 05.
Article in En | MEDLINE | ID: mdl-34942182
Although gonadotropin-releasing hormone analogs are the standard of care for the treatment of central precocious puberty, they are not approved for children/< age 2 years. We reviewed experience with the use of gonadotropin-releasing hormone analogs in 47 children younger than age 2 years, which revealed efficacy and safety comparable with that in older children.
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Puberty, Precocious Limits: Child / Child, preschool / Humans Language: En Journal: J Pediatr Year: 2022 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Puberty, Precocious Limits: Child / Child, preschool / Humans Language: En Journal: J Pediatr Year: 2022 Document type: Article Country of publication: United States